UCLA Radiation Oncology at ASTRO 2025 - Flipbook - Page 3
SUNDAY, SEPTEMBER 28, 2025
Sunday, September 28 at 1:10PM
SESSION: CT 01 3 CLINICAL TRIALS / 177 Lutetium-PSMA Neoadjuvant to Ablative
Radiotherapy for Oligorecurrent Prostate Cancer; Primary Endpoint Analysis of the
Phase II LUNAR Randomized Trial
SPEAKER: AMAR KISHAN, MD
LOCATION: San Francisco Ballroom
Sunday, September 28 at 2:30PM
SESSION: PQA 01 - Radiation and Cancer Physics, Sarcoma and Cutaneous Tumors /
2202 3 Harnessing Deep Learning on Fractional Dosimetry for Acute Genitourinary
Toxicity Prediction Following Prostate SBRT
PRESENTER: SHARON XIANGRONG QI, PHD
LOCATION: Hall F
Sunday, September 28 at 2:45PM
SESSION: EDU 05 3 Trial Androgen Deprivation Therapy and Dose Escalation for
Prostate Cancer: Lessons from Randomized Trials and the MARCAP Consortium
MODERATOR / SPEAKER: AMAR KISHAN, MD
LOCATION: Room 20/21
Sunday, September 28 at 2:45PM
SESSION: SS 06 3 Radiation and Cancer Biology 1: Factors Mediating
Radioresistance / 139 3 Genomic and Transcriptomic Profiling of Radiation
Resistant, Locally Recurrent Prostate Cancer
MODERATOR / SPEAKER: BETH NEILSEN, MD, PHD
LOCATION: Room 155 / 157
Sunday, September 28 at 4:45PM
SESSION: PQA 02 3 Lung Cancer/Thoracic Malignancies, Patient Reported Outcomes,
QoL, Survivorship, Pediatric Cancer/ 2440 Fifteen Year Trends In Single-Fraction
SBRT Utilization for Stage I Non-Small Cell Lung Cancer
MODERATOR / SPEAKER: DREW MOGHANAKI, MD, MPH, FASTRO
LOCATION: Hall F
